Serge Belanger
Stock Analyst at Needham
(4.65)
# 190
Out of 5,115 analysts
385
Total ratings
57.06%
Success rate
26.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $30 → $31 | $25.38 | +22.14% | 24 | Jan 26, 2026 | |
| KALV KalVista Pharmaceuticals | Maintains: Buy | $32 → $35 | $15.73 | +122.50% | 24 | Jan 9, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 | $20.47 | +46.56% | 29 | Jan 9, 2026 | |
| CRMD CorMedix | Maintains: Buy | $16 → $15 | $7.76 | +93.30% | 20 | Jan 8, 2026 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $48 → $56 | $46.06 | +21.58% | 27 | Jan 8, 2026 | |
| EOLS Evolus | Reiterates: Hold | n/a | $4.70 | - | 17 | Dec 24, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $34 → $42 | $32.97 | +27.39% | 19 | Dec 23, 2025 | |
| CYTK Cytokinetics | Maintains: Buy | $72 → $84 | $63.71 | +31.85% | 26 | Dec 22, 2025 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $20 | $9.19 | +117.63% | 6 | Dec 8, 2025 | |
| OCS Oculis Holding AG | Reiterates: Buy | $36 | $28.21 | +27.61% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $34 | $26.42 | +28.69% | 8 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $46 | $31.09 | +47.96% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $6.58 | +173.76% | 18 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $52 | $42.60 | +22.07% | 34 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $40.89 | +34.51% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $11.77 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $20 | $15.78 | +26.74% | 14 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.32 | +128.14% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $22 | $10.64 | +106.77% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.08 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $3.42 | +16.96% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.41 | - | 1 | Mar 31, 2022 |
Arcutis Biotherapeutics
Jan 26, 2026
Maintains: Buy
Price Target: $30 → $31
Current: $25.38
Upside: +22.14%
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $32 → $35
Current: $15.73
Upside: +122.50%
Pacira BioSciences
Jan 9, 2026
Maintains: Buy
Price Target: $30
Current: $20.47
Upside: +46.56%
CorMedix
Jan 8, 2026
Maintains: Buy
Price Target: $16 → $15
Current: $7.76
Upside: +93.30%
Collegium Pharmaceutical
Jan 8, 2026
Maintains: Buy
Price Target: $48 → $56
Current: $46.06
Upside: +21.58%
Evolus
Dec 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.70
Upside: -
Viridian Therapeutics
Dec 23, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $32.97
Upside: +27.39%
Cytokinetics
Dec 22, 2025
Maintains: Buy
Price Target: $72 → $84
Current: $63.71
Upside: +31.85%
Ocular Therapeutix
Dec 8, 2025
Reiterates: Buy
Price Target: $20
Current: $9.19
Upside: +117.63%
Oculis Holding AG
Nov 11, 2025
Reiterates: Buy
Price Target: $36
Current: $28.21
Upside: +27.61%
Nov 7, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $26.42
Upside: +28.69%
Nov 5, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $31.09
Upside: +47.96%
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $6.58
Upside: +173.76%
Nov 4, 2025
Maintains: Buy
Price Target: $36 → $52
Current: $42.60
Upside: +22.07%
Nov 4, 2025
Reiterates: Buy
Price Target: $55
Current: $40.89
Upside: +34.51%
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.77
Upside: -
Sep 30, 2025
Maintains: Buy
Price Target: $66 → $20
Current: $15.78
Upside: +26.74%
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.32
Upside: +128.14%
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $10.64
Upside: +106.77%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.08
Upside: -
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $3.42
Upside: +16.96%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.41
Upside: -